Since Jeffrey Epstein’s death in 2019, wave after wave of evidence has put him at the centre of a wide-ranging network of sex ...

Since Jeffrey Epstein’s death in 2019, wave after wave of evidence has put him at the centre of a wide-ranging network of sex ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

A test using a zebrafish model helped clinicians rule out SMA in two children, showing its potential use to clarify genetic ...

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...

New U.S. dietary guidelines promote eating full-fat foods and meats. But experts say nuts and seed oils are better sources of ...

TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement ...

DF-003 is the first ALPK1 inhibitor to successfully complete a first-in-human Phase 1 study and has now entered a Phase 1b clinical trial in patients with ROSAH syndrome (NCT06395285), where it is ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

According to research from a team at the University of Utah Health and the University of Nevada, Reno School of Medicine, ...